Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020
- PMID: 33270611
- PMCID: PMC7714028
- DOI: 10.15585/mmwr.mm6948e1
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020
Abstract
Carbapenem-resistant Acinetobacter baumannii (CRAB), an opportunistic pathogen primarily associated with hospital-acquired infections, is an urgent public health threat (1). In health care facilities, CRAB readily contaminates the patient care environment and health care providers' hands, survives for extended periods on dry surfaces, and can be spread by asymptomatically colonized persons; these factors make CRAB outbreaks in acute care hospitals difficult to control (2,3). On May 28, 2020, a New Jersey hospital (hospital A) reported a cluster of CRAB infections during a surge in patients hospitalized with coronavirus disease 2019 (COVID-19). Hospital A and the New Jersey Department of Health (NJDOH) conducted an investigation, and identified 34 patients with hospital-acquired multidrug-resistant CRAB infection or colonization during February-July 2020, including 21 (62%) who were admitted to two intensive care units (ICUs) dedicated to caring for COVID-19 patients. In late March, increasing COVID-19-related hospitalizations led to shortages in personnel, personal protective equipment (PPE), and medical equipment, resulting in changes to conventional infection prevention and control (IPC) practices. In late May, hospital A resumed normal operations, including standard IPC measures, as COVID-19 hospitalizations decreased, lessening the impact of personnel and supply chain shortages on hospital functions. CRAB cases subsequently returned to a pre-COVID-19 baseline of none to two cases monthly. The occurrence of this cluster underscores the potential for multidrug-resistant organisms (MDROs) to spread during events when standard hospital practices might be disrupted; conventional IPC strategies should be reinstated as soon as capacity and resources allow.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures
Similar articles
-
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15. Microb Pathog. 2019. PMID: 30562602
-
Investigation of an outbreak of carbapenem resistant Acinetobacter baumannii in an intensive care unit during the COVID-19 epidemic.Antimicrob Resist Infect Control. 2025 Apr 12;14(1):30. doi: 10.1186/s13756-025-01547-0. Antimicrob Resist Infect Control. 2025. PMID: 40221801 Free PMC article.
-
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study.Antimicrob Resist Infect Control. 2021 Apr 8;10(1):69. doi: 10.1186/s13756-021-00919-6. Antimicrob Resist Infect Control. 2021. PMID: 33832538 Free PMC article.
-
The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis.Emerg Microbes Infect. 2019;8(1):1747-1759. doi: 10.1080/22221751.2019.1698273. Emerg Microbes Infect. 2019. PMID: 31805829 Free PMC article.
-
Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.J Infect Dev Ctries. 2009 Jun 1;3(5):335-41. doi: 10.3855/jidc.240. J Infect Dev Ctries. 2009. PMID: 19759502 Review.
Cited by
-
Differential Gene Expression of Efflux Pumps and Porins in Clinical Isolates of MDR Acinetobacter baumannii.Life (Basel). 2022 Mar 14;12(3):419. doi: 10.3390/life12030419. Life (Basel). 2022. PMID: 35330171 Free PMC article.
-
Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic.Antibiotics (Basel). 2022 Feb 25;11(3):315. doi: 10.3390/antibiotics11030315. Antibiotics (Basel). 2022. PMID: 35326778 Free PMC article. Review.
-
Analysis of Lung Microbiome in COVID-19 Patients during Time of Hospitalization.Pathogens. 2023 Jul 17;12(7):944. doi: 10.3390/pathogens12070944. Pathogens. 2023. PMID: 37513791 Free PMC article.
-
Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit.Can J Infect Dis Med Microbiol. 2023 Sep 14;2023:4951273. doi: 10.1155/2023/4951273. eCollection 2023. Can J Infect Dis Med Microbiol. 2023. PMID: 37745269 Free PMC article.
-
Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks.Life (Basel). 2021 Mar 10;11(3):220. doi: 10.3390/life11030220. Life (Basel). 2021. PMID: 33801799 Free PMC article. Review.
References
-
- CDC. Antibiotic resistance threats in the United States 2019. Atlanta, GA: US Department of Health and Human Services, CDC; 2019.
-
- Chen CH, Lin LC, Chang YJ, Chen YM, Chang CY, Huang CC. Infection control programs and antibiotic control programs to limit transmission of multi-drug resistant Acinetobacter baumannii infections: evolution of old problems and new challenges for institutes. Int J Environ Res Public Health 2015;12:8871–82. 10.3390/ijerph120808871 - DOI - PMC - PubMed
-
- Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–81. 10.1111/j.1469-0691.2011.03570.x - DOI - PubMed
-
- CDC. Healthcare-associated infections: tracking CRE in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/hai/organisms/cre/trackingcre.html
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical